EUVIMEDEUVIMED entdecken
Crossref

Current diagnosis and screening of hydroxychloroquine retinopathy

Hüseyin Egemen Köse, Mehmet Çıtırık

Archives of Ophthalmological Research · 2024

DOI: 10.51271/aor-0013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Ophthalmological Research, 2024. Verfasst von Hüseyin Egemen Köse und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hydroxychloroquine-associated retinopathy is an important cause of progressive visual loss that is increasingly being diagnosed with the growing use of hydroxychloroquine and modern imaging techniques. Hydroxychloroquine acts through complex mechanisms and is commonly used to treat rheumatological and dermatological diseases. Optical coherence tomography, fundus autofluorescence, and automated perimetry are commonly used in retinal clinics for the diagnosis and monitoring of hydroxychloroquine-associated retinopathy. Owing to the potential for irreversible central visual loss with the development of retinopathy, early detection of toxicity is crucial. Advances in technology, wide-field imaging devices, new optical coherence tomography techniques and parameters, fundus autofluorescence techniques, and imaging methods such as optical coherence tomography angiography offer promise for the early detection of toxicity.

Zitieren

APA

Köse, H. E., & Çıtırık, M. (2024). Current diagnosis and screening of hydroxychloroquine retinopathy. Archives of Ophthalmological Research. https://doi.org/10.51271/aor-0013

Vancouver

Köse HE, Çıtırık M. Current diagnosis and screening of hydroxychloroquine retinopathy. Archives of Ophthalmological Research. 2024. doi:10.51271/aor-0013

BibTeX
@article{Kse2024,
  author = {Köse, Hüseyin Egemen and Çıtırık, Mehmet},
  title = {Current diagnosis and screening of hydroxychloroquine retinopathy},
  journal = {Archives of Ophthalmological Research},
  year = {2024},
  doi = {10.51271/aor-0013}
}
Kostenlos starten →